Keywords
Tumor microenvironmentCancerT cellCancer researchCancer cellImmunotherapyImmunityCellBiologyMedicineImmunologyBioinformaticsImmune systemInternal medicineGenetics
Affiliated Institutions
Related Publications
Cancer Immunotherapy Comes of Age
Cancer immunotherapy comprises a variety of treatment approaches, incorporating the tremendous specificity of the adaptive immune system (T cells and antibodies) as well as the ...
CD8<sup>+</sup> cytotoxic T lymphocytes in cancer immunotherapy: A review
Abstract CD8 + cytotoxic T lymphocytes (CTLs) are preferred immune cells for targeting cancer. During cancer progression, CTLs encounter dysfunction and exhaustion due to immune...
<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates
Abstract The programmed death-1 (PD-1) receptor serves as an immunologic checkpoint, limiting bystander tissue damage and preventing the development of autoimmunity during infla...
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) functions as a negative regulator of endogenous and vaccine-induced antitumor immunity. The administration of fully human an...
The future of immune checkpoint therapy
Immune checkpoint therapy, which targets regulatory pathways in T cells to enhance antitumor immune responses, has led to important clinical advances and provided a new weapon a...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 33
- Issue
- 4
- Pages
- 547-562
- Citations
- 1222
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1222
OpenAlex
Cite This
Daniela S. Thommen,
Ton N. Schumacher
(2018).
T Cell Dysfunction in Cancer.
Cancer Cell
, 33
(4)
, 547-562.
https://doi.org/10.1016/j.ccell.2018.03.012
Identifiers
- DOI
- 10.1016/j.ccell.2018.03.012